Surgical blood loss during femoral rodding in children with osteogenesis imperfecta
✍ Scribed by Carmen P. Pichard; Raymond E. Robinson; Richard L. Skolasky; Neal S. Fedarko; Arabella I. Leet
- Book ID
- 107517883
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 159 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1863-2521
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
21.4% of children developed hearing loss, a percentage similar to previous population studies. • Since all received treatment, we cannot determine directly bisphosphonate effects on hearing loss over time. • However, it appears that bisphosphonates neither increase hearing loss nor stop progression
Osteogenesis imperfecta (OI) is a heritable bone fragility disorder characterized by skeletal deformities and increased bone fragility. There is currently no established clinical method for quantifying fracture risk in OI patients. This study begins the development of a patient-specific model for fe